Allermi
PrivateLast Round
Seed
Mar 16, 2023
Total Funding Raised
$4.75M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Allermi is a healthtech company that provides a direct-to-consumer telehealth service for customized prescription nasal sprays to treat allergy symptoms.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, D2C Brands, Subscription Commerce, Patient Engagement
Business Model
B2C
Customer Profile
Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allermi Comparables
Compare Allermi with similar companies based on industry and business-model similarity.
Allermi Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 16, 2023 | ||||
| Pre Seed | Sep 8, 2022 |
Key People
Founding team and executive leadership
Allermi Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FourSight Capital Partners | Seed |
| Lucas Venture Group | Pre Seed |
| Nelstone Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors increased 37% MoM.
- Apr 2, 2026
Monthly visitors increased 64% MoM, reaching over 100K.
Allermi Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Allermi's valuation, stock price, and market status.